Therapeutic Vaccine Adjuvants
Adjuvant technologies for active immunotherapy
Immunotherapy has become a corner stone of combined therapies for cancers, HIV, hepatitis, auto-immune and other diseases. With a lot of promising results in oncotherapy, therapeutic vaccines are an interesting alternative in the active immunotherapy field.
Self antigens used in this field are more defined but are linked with weak and too brief immune response. Antigens may be associated with enhancers such as adjuvants to improve the immune response induced. Water-in-oil emulsions represent an interesting choice for therapeutic vaccines where powerful adjuvants are required.
MONTANIDE™ ISA 51 VG and MONTANIDE™ ISA 720 VG
As a key expert and reference supplier of vaccine adjuvants, SEPPIC has been offering effective adjuvants for therapeutic vaccines over twenty years. MONTANIDE™ ISA 51 VG and MONTANIDE™ISA 720 VG are two major ingredients for therapeutic vaccines.
These ready to use oil adjuvants are suitable for human injection and are used for manufacturing of water in oil emulsions with an easy process.
SEPPIC implements Good Manufacturing Practices (GMP), from raw materials to Quality Assurance batch release. Adjuvants are produced under aseptic conditions in a pharmaceutical facility.